Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine
Radiation Oncology
Dr. Philip P. Connell, MD
|
|
Give Review
Philip P. Connell, MD is an expert in the field of Radiation Oncology. He studied medicine at New York Medical College. He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Philip Connell is also a published MD. He has 46 publication published. The most recent publication is: Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. He is registered with Medicare and accepts Medicare payments.
Publications
- Strategies to Overcome Late Complications from Radiotherapy for Childhood Head and Neck Cancers.
- RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.
- DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy.
- Small molecule derived from a natural product that mitigates radiation injury.
- Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing.
- New paradigms and future challenges in radiation oncology: an update of biological targets and technology.
- An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma.
- An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity.
- Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer.
- Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
- A downside to apoptosis in cancer therapy?
- Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.
- Advances in radiotherapy and implications for the next century: a historical perspective.
- A chemical compound that stimulates the human homologous recombination protein RAD51.
- The Yin and Yang of treating BRCA-deficient tumors.
- Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
- A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
- A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin.
- Gene therapy: the challenges of translating laboratory research into clinical practice.
- Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells.
- Endogenous endophthalmitis: 10-year experience at a tertiary referral centre.
- Long term follow up of nasolacrimal intubation in adults.
- The significance of adnexal involvement in endometrial carcinoma.
- Race and clinical outcome in endometrial carcinoma.
- Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.
- Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
- Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma.
- Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma?
- External pelvic radiation therapy in stage IC endometrial carcinoma.
- Outcome of endometrial carcinoma patients with involvement of the uterine serosa.
- Age as a prognostic factor for recurrence in patients with endometrial carcinoma.
- Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results.
- Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy.
- One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy.
- Synchronous ovarian and endometrial malignancies.
- Characteristics and outcome of endometrial carcinoma patients age 45 years and younger.
- What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?
- Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
- Surgery and postoperative radiation therapy in stage II endometrial carcinoma.
- Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagus.
- Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation...
- Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.
- Relevance and irrelevance of DNA damage response to radiotherapy.
- Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
- Radiotherapy for pediatric brain tumors: when and how.
Schools
New York Medical College
Saint Vincent39s Hospital
University of Chicago
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Choice
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- HealthLink PPO
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
New York Medical College
Hospital
-
University of Chicago Medical Center -
University of Illinois Hospital & Health Sciences System -
Jesse Brown Veterans Affairs Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538228077 |
| Last Name Of The Provider | CONNELL |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Daniel J. Haraf, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Azhar M. Awan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Chmura, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Samuel Hellman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard J. Halpern, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Harold G. Sutton, MD
This Doctor is OpenDoctor Recommended.
|